Gelsemium significantly reduced AChE activity in comparison to SCO-treated mice (p < 0.01).Gelsemium pre-treatment in SCO-injected mice profoundly decreased mRNA expression level of AChE in comparison to only SCO-treated dementia mice. The gene discussed is ACHE; the disease is dementia.